Vanda Pharmaceuticals' GAAP net profit for 9M 2021 was $26.074 mln, up 72.1% compared to $15.147 mln in the previous year. Revenue increased 11.2% to $200.663 million from $180.515 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept